 WEST LAFAYETTE, Ind., Nov. 01, 2022 GLOBE NEWSWIRE -- Inotiv, Inc. Nasdaq: NOTV the Company, We, Our or Inotiv, a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today that Robert Leasure Jr., President and Chief Executive Officer, and Beth Taylor, Chief Financial Officer, are scheduled to participate in the following investor conferences during the month of November: 